Background Tofacitinib is the first Janus Kinase (JAK) inhibitor available in China, and it has significantly improved the efficacy of treatment of rheumatoid arthritis (RA). Previous clinical trials ...

Pemphigus foliaceus treated with minocycline monotherapy or low-dose prednisolone combination therapy.